In vitro studies have demonstrated that DFO can inhibit the degradation of type II collagen in osteoarthritis cartilage while also reducing the expression of inflammatory factors such as MMP-1, MMP-13, IL-1β, and TNF-α (Tchetina et al., 2016). The gene discussed is IL1B; the disease is osteoarthritis.